These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 4600291)

  • 21. New advances in typhoid Fever vaccination strategies.
    Bhutta ZA; Khan MI; Soofi SB; Ochiai RL
    Adv Exp Med Biol; 2011; 697():17-39. PubMed ID: 21120717
    [No Abstract]   [Full Text] [Related]  

  • 22. [Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
    Gekker VD; Sergeeva NS
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):14-8. PubMed ID: 4780106
    [No Abstract]   [Full Text] [Related]  

  • 23. A study on the booster effect of typhoid vaccines.
    Varma RN; Boparai MA; Murthy RG
    Indian J Public Health; 1973; 17(3):91-100. PubMed ID: 4802379
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)].
    Hatunceva NV; Mironova MV; Ryapolova RG
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):135-41. PubMed ID: 4216248
    [No Abstract]   [Full Text] [Related]  

  • 25. Why are typhoid vaccines not recommended for epidemic typhoid fever?
    Taylor DN; Levine MM; Kuppens L; Ivanoff B
    J Infect Dis; 1999 Dec; 180(6):2089-90. PubMed ID: 10558978
    [No Abstract]   [Full Text] [Related]  

  • 26. [The role of H-antigen in postvaccinal immunity against typhoid and paratyphoid].
    Kheĭfets LB; Stanislavskiĭ ES; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):113-4. PubMed ID: 4218035
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical experience with typhoid vaccine in Thailand.
    Sarasombath S
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):471-4. PubMed ID: 3064324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
    Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
    Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse protective capabilities of Escherichia coli hybrids expressing Salmonella typhi antigens.
    Diena BB; Lior H; Ryan A; Krol P; Johnson EM; Baron LS
    Infect Immun; 1979 Apr; 24(1):90-3. PubMed ID: 378849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
    Paliwal PK; Bansal A; Sagi SS; Sairam M
    Vaccine; 2011 Sep; 29(38):6532-9. PubMed ID: 21767594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials.
    Arya SC; Agarwal N
    Vaccine; 2008 Jan; 26(3):291. PubMed ID: 18082292
    [No Abstract]   [Full Text] [Related]  

  • 32. Advances in vaccines for typhoid fever.
    Gupta A; Jalla S; Sazawal S; Bhan MK
    Indian J Pediatr; 1994; 61(4):321-39. PubMed ID: 8002060
    [No Abstract]   [Full Text] [Related]  

  • 33. Typhoid-paratyphoid (TAB) vaccine as interferon inducer in mice.
    Kandefer-Szerszeń M
    Acta Microbiol Pol A; 1973; 5(3):156-62. PubMed ID: 4358715
    [No Abstract]   [Full Text] [Related]  

  • 34. A Salmonella typhi Vi conjugate vaccine.
    Koul PA
    N Engl J Med; 2001 Aug; 345(7):545-6. PubMed ID: 11519517
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccines against typhoid fever.
    Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
    Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of autoantibody formation following immunization with different types of typhoid vaccines].
    Negina IuP
    Zh Mikrobiol Epidemiol Immunobiol; 1980 May; (5):69-72. PubMed ID: 7415680
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Monoclonal antibodies against the lipopolysaccharide of Salmonella typhi 9,12,VI:d. Analysis of passive protection in a mouse model of typhoid fever].
    Paniagua J; Isibasi A; Pelayo R; Ortiz V; Muy M; González C; García JA; Islas S
    Arch Invest Med (Mex); 1989; 20(4):315-20. PubMed ID: 2488771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization against typhoid: a short review.
    Bhatia RS; Sibia SS
    J Assoc Physicians India; 1994 May; 42(5):424. PubMed ID: 7829448
    [No Abstract]   [Full Text] [Related]  

  • 40. Research on the oral antityphoid immunization in mice and its mechanism of action.
    De Barbieri A; Tassi CG; Crovari P; Chiappino G
    Prog Immunobiol Stand; 1970; 4():386-8. PubMed ID: 4991590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.